Kidney transplantation from deceased donors with high terminal serum creatinine.
The increasing number of possible recipients for kidney transplantation and relatively unchanged number of organ donors has led to consideration of alternative strategies and expansion of deceased donor criteria in order to expand donor pool. Previously, kidneys from expanded criteria donors (ECD) were strongly underestimated because of the conventional opinion suggesting these kidneys to have a higher rate of preservation injury, delayed graft function, rejection and nonfunction. Reducing the difference between graft outcome in patients transplanted from ECD and standard criteria donor (SCD) is one of the goals of many respectable kidney transplantation centers. This assignment includes major concern about reduction of cold ischemia time, recipient selection, novel and adapted immunosuppressive regimens, increased nephron mass by dual kidney transplantation, and using histologic criteria for marginal donor graft selection. There are not many reports on the outcome of kidneys transplanted from donors with acute renal failure and high terminal creatinine. This review presents the exact definition of marginal donor, especially donor with acute renal failure. The management of such grafts during preimplantation and implantation period, outcomes and post-transplantation care are the main assignments for transplantation teams. Recipients of such grafts should be well informed about the possibilities and potential complications and sign their informed consent thereafter. Some respectable studies have shown that under certain, highly controlled conditions, these kidneys can be used safely, with excellent short- and long-term outcomes.
Department of Anesthesiology, Resuscitation and Intensive Care, Zagreb University Hospital Center, Zagreb, Croatia. bacakkocman.iva@gmail.com
Iva Bacak
IB
Kocman
Lea
L
Katalinić
Zeljko
Z
Kastelan
Petar
P
Kes
Ivica
I
Kocman
Eleonora
E
Goluza
Mladen
M
Perić
Nikolina Basić
NB
Jukić
D058186:Acute Kidney Injury; D003404:Creatinine / Q000097:blood*; D046148:Donor Selection; D006801:Humans; D016030:Kidney Transplantation; D014019:Tissue Donors; D016896:Treatment Outcome
D003404:Creatinine